YZYanhong Zhao

Yanhong Zhao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yanhong Zhao has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Bihua Deng

    National Research Center for Veterinary Vaccine Engineering and Technology of China, Jiangsu Academy of Agricultural Sciences, Nanjing, China

    1 shared publication
  • Chan Ding

    Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, China

    1 shared publication
  • Fang Lv

    National Research Center for Veterinary Vaccine Engineering and Technology of China, Jiangsu Academy of Agricultural Sciences, Nanjing, China

    1 shared publication
  • Jibo Hou

    National Research Center for Veterinary Vaccine Engineering and Technology of China, Jiangsu Academy of Agricultural Sciences, Nanjing, China

    1 shared publication
  • Jinfeng Miao

    College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China

    1 shared publication
  • Jinqiu Zhang

    College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, 210095, China; Institute of Veterinary Immunology & Engineering, Jiangsu Academy of Agricultural Sciences, Nanjing, 210014, China; Engineering Research Center for the Prevention and Control of Animal Original Zoonosis & College of Life Science, Longyan University, Longyan, 364012, China; College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, 030801, China

    1 shared publication

Latest Publications

  • Open Access

    Development of a novel oil-in-water emulsion and evaluation of its potential adjuvant function in a swine influenza vaccine in mice

    by Jinqiu Zhang, Jinfeng Miao, Xiangan Han, Yu Lu, Bihua Deng, Fang Lv, Yanhong Zhao, Chan Ding, Jibo Hou

    Vaccination is the principal strategy for prevention and control of diseases, and adjuvant use is an effective strategy to enhance vaccine efficacy. Traditional mineral oil-based adjuvants have been reported with post-immunization reactions. Developing new adjuvant formulations with improved potency and safety will be of great value. In the study reported herein, a novel oil-in-water (O/W) Emulsion Adjuvant containing Squalane (termed EAS) was developed, characterized and investigated for swine influenza virus immunization. The data show that EAS is a homogeneous nanoemulsion with small particle size (~ 105 nm), low viscosity (2.04 ± 0.24 cP at 20 °C), excellent stability (at least 24 months at 4 °C) and low toxicity. EAS-adjuvanted H3N2 swine influenza vaccine was administrated in mice subcutaneously to assess the adjuvant potency of EAS. The results demonstrated that in mice EAS-adjuvanted vaccine induced significantly higher titers of hemagglutination inhibition (HI) and IgG antibodies than water-in-oil (W/O) vaccines or antigen alone, respectively, at day 42 post vaccination (dpv) (P < 0.05). EAS-adjuvanted vaccine elicited significantly stronger IgG1 and IgG2a antibodies and higher concentrations of Th1 (IFN-γ and IL-2) cytokines compared to the W/O vaccine or antigen alone. Mice immunized with EAS-adjuvanted influenza vaccine conferred potent protection after homologous challenge. The O/W emulsion EAS developed in the present work induced potent humoral and cellular immune responses against inactivated swine influenza virus, conferred effective protection after homologous virus challenge and showed low toxicity in mice, indicating that EAS is as good as the commercial adjuvant MF59. The superiority of EAS to the conventional W/O formulation in adjuvant activity, safety and stability will make it a potential veterinary adjuvant.